An article published in the Journal of the American Medical Association Neurology reports that those who consumed high levels of omega-3 fatty acids
had a dramatically reduced risk of developing amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) in a meta-analysis of five large studies.
Even though the quantity of ethanol released after taking a typical dose of fish oil for supplementation is small, at-risk groups such as pregnant and lactating women, as well as young children, should avoid using omega-3 fatty acid
supplements that contain EEs.
According to the study, led by the University of Pittsburgh Graduate School of Public Health, middle-aged men in Japan had lower incidence of coronary artery calcification, a predictor of heart disease, than middle-aged white men living in the US, likely due to the significantly higher consumption of omega-3 fatty acids
found in fish.
Moreover, while consuming seafood rich in omega-3 fatty acids
is known to reduce risk of heart disease, there had been questions as to whether the baking process causes a loss of omega -3s in farm-raised Atlantic salmon.
A recent meta-analysis raises significant questions about the role of omega-3 fatty acids
in heart disease in the general population.
Determining through further research whether omega-3 fatty acids
or other nutrients relate to spinal fluid or brain beta-amyloid levels, or levels of other Alzheimer's disease-related proteins, can strengthen our confidence on beneficial effects of parts of our diet in preventing dementia.
Low levels of all omega-3 fatty acids
were also associated with poor test scores for visual memory, problem-solving, multi-tasking and abstract thinking.
Animal trials show that omega-3 fatty acid
treatment decreases blood pressure, has anti-inflammatory effects, slows renal failure and moderates the side effects of hypertension (Imig et al.
bases its recommendations of omega-3 fatty acids
on risk for coronary heart disease and provides guidelines for intakes of foods with omega-6's.
A Placebo Controlled Trial of Omega-3 Fatty Acid
(Ethyl-Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia," Am.
Eggs, meat and dairy products enriched with omega-3 fatty acids
are now available to the Canadian consumer.
ORLANDO -- Daily treatment of recent myocardial infarction patients with an omega-3 fatty acid
supplement for 1 year failed to show a beneficial effect on the rate of sudden cardiac death or other adverse cardiovascular events in a controlled trial of about 3,800 patients.
TORONTO -- Patients with cardiovascular disease on an oral regimen of omega-3 fatty acid
had a 73% reduced risk for developing atrial fibrillation in a retrospective, observational study of more than 11,000 patients.
Proprietary processing technology ensures 32% omega-3 fatty acid
content, while nitrogen purging and welded seal caps prevent loss from oxidation.
Two placebo-controlled clinical trials studied omega-3 fatty acid